iBio (IBIO) Times Interest Earned (2010 - 2026)
iBio (IBIO) posted quarterly Times Interest Earned of -$59.33 for Q1 2026, down 71.45% year-over-year from -$207.79 in Q1 2025, and up 11.43% quarter-over-quarter from -$66.99 in Q4 2025.
iBio (IBIO) Times Interest Earned (2010 - 2026) Analysis & Trends
iBio (IBIO) has reported Times Interest Earned for 17 consecutive years, with -$59.33 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned fell 71.45% year-over-year to -$59.33; the TTM figure through Mar 2026 stood at -$782.68 (down 170.0% YoY), while the FY2025 annual figure was -$0.29, up 3.24% from the prior year.
- Times Interest Earned grew to -$59.33 in Q1 2026 per IBIO's latest filing, from -$66.99 in the prior quarter.
- Across five years, Times Interest Earned topped out at $209.06 in Q2 2022 and bottomed at -$165.31 in Q3 2025.
- Historically, Times Interest Earned has averaged -$16.48 across 5 years, with a median of -$14.25 in 2023.
- On a YoY basis, Times Interest Earned climbed as much as 1451.06% in 2022 and fell as far as 4581.56% in 2022.
- iBio's Times Interest Earned stood at -$2.91 in 2022, then plunged by 389.69% to -$14.23 in 2023, then slumped by 120.28% to -$31.34 in 2024, then sank by 113.74% to -$66.99 in 2025, then climbed by 11.43% to -$59.33 in 2026.
- Business Quant data shows IBIO's Times Interest Earned at -$59.33 in Q1 2026, -$66.99 in Q4 2025, and -$165.31 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | -380.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.33 |
| Dec 31, 2025 | -66.99 |
| Sep 30, 2025 | -165.31 |
| Jun 30, 2025 | 18.50 |
| Mar 31, 2025 | -34.60 |
| Dec 31, 2024 | -31.34 |
| Sep 30, 2024 | -72.04 |
| Jun 30, 2024 | 12.13 |
| Mar 31, 2024 | -25.72 |
| Dec 31, 2023 | -14.23 |
| Sep 30, 2023 | -14.25 |
| Jun 30, 2023 | -5.95 |
| Mar 31, 2023 | -1.71 |
| Dec 31, 2022 | -2.91 |
| Sep 30, 2022 | -7.64 |
| Jun 30, 2022 | 209.06 |
| Mar 31, 2022 | -17.82 |
| Dec 31, 2021 | -35.80 |
| Sep 30, 2021 | -0.16 |
| Jun 30, 2021 | -15.47 |